Loading
Saturday, October 17, 2026 · Vol. I, No. 42Independent · Canadian · Research-first
Before you compare Canadian research sourcesRun the free 10-point COA + batch audit at LynxLabs →
BPC-157 · research summary
Scientific reports · 2026. Summary drawn from the study's full text. Each statement is followed by the exact sentence it comes from. This is a research summary, not medical advice.
Experimental animal study evaluating the protective effects of BPC 157 in a rat model of lower limb ischemia-reperfusion injury.
“This study aimed to evaluate the protective effects of BPC 157 in a rat model of lower limb I/R injury.”
Male Wistar albino rats.
“Twenty-four male Wistar albino rats were randomized into four groups (n = 6): SHAM, B (BPC 157 only), IR (I/R), and IRB (I/R + BPC 157).”
24 rats total, divided into four groups of 6 animals each.
“Twenty-four male Wistar albino rats were randomized into four groups (n = 6): SHAM, B (BPC 157 only), IR (I/R), and IRB (I/R + BPC 157).”
45 minutes of ischemia followed by 2 hours of reperfusion.
“I/R was induced by abdominal aortic clamping for 45 min followed by 2 h of reperfusion.”
BPC 157 administration reduced oxidative stress markers (MDA, TOS) and restored antioxidant levels (SOD, TAS) compared to the ischemia-reperfusion group.
“In the IRB group, BPC 157 reduced MDA and TOS, restored SOD and TAS, downregulated p53, Bax, and Casp3, reduced IL-6 and Caspase-3 immunoreactivity, and partially restored VEGF expression.”
Source: PubMed 42204242 · DOI 10.1038/s41598-026-55449-1 · all study summaries